4.6 Article

Detection of protein aggregates in brain and cerebrospinal fluid derived from multiple sclerosis patients

Related references

Note: Only part of the references are listed.
Article Immunology

Potential candidate camelid antibodies for the treatment of protein-misfolding diseases

Monique Antoinette David et al.

JOURNAL OF NEUROIMMUNOLOGY (2014)

Article Biochemistry & Molecular Biology

Decreased activity of the 20S proteasome in the brain white matter and gray matter of patients with multiple sclerosis

Jianzheng Zheng et al.

JOURNAL OF NEUROCHEMISTRY (2011)

Article Multidisciplinary Sciences

PrPSc-Specific Antibodies with the Ability to Immunodetect Prion Oligomers

Mourad Tayebi et al.

PLOS ONE (2011)

Article Clinical Neurology

Antibodies Produced by Clonally Expanded Plasma Cells in Multiple Sclerosis Cerebrospinal Fluid

Gregory P. Owens et al.

ANNALS OF NEUROLOGY (2009)

Article Clinical Neurology

CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients

F. G. Joseph et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)

Article Multidisciplinary Sciences

Intracerebroventricular amyloid-β antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice

Deepak R. Thakker et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Review Infectious Diseases

A role for B lymphocytes in anti-infective prion therapies?

Mourad Tayebi et al.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2007)

Article Immunology

B-cell differentiation in the CNS of patients with multiple sclerosis

A Corcione et al.

AUTOIMMUNITY REVIEWS (2005)